OrthoPediatrics Corp.

OrthoPediatrics Corp. is a medical device company that designs, develops, and markets anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions. Headquartered in Warsaw, Indiana, the company was organized in November 2007 as a Delaware corporation, having initially formed as an Indiana limited liability company on August 31, 2006. Its common stock trades on the Nasdaq Global Market under the symbol KIDS. OrthoPediatrics Corp. sells specialized products such as PediLoc®, PediPlates®, Cannulated Screws, PediFlex™ nail, PediNail™, PediLoc® Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE™ Spine, BandLoc™, Pediatric Nailing Platform | Femur, Devise Rail, Orthex®, The Fassier-Duval Telescopic Intramedullary System®, SLIM™ Nail, The GAP Nail™, The Free Gliding SCFE Screw System™, GIRO™ Growth Modulation System, PNP Tibia System, ApiFix® Mid-C System, Mitchell Ponseti®, VerteGlide™, and Boston Brace 3D® specialized bracing products. These products are sold to hospitals and medical facilities across the United States and various international markets. The company uses a contract manufacturing model for implants and surgical instrumentation, while orthopedic bracing products are typically manufactured in-house. OrthoPediatrics Corp. also operates multiple orthotic and prosthetic ("O&P") clinics that provide pediatric non-surgical O&P treatment. The company began selling products in the United States in 2008 and internationally in 2011. In 2017, it expanded operations by establishing legal entities in the United Kingdom, Australia, and New Zealand, allowing direct sales to local hospitals via an agency model. Direct sales began in Canada in September 2018, Belgium and the Netherlands in January 2019, Italy in March 2020, and Germany, Switzerland, and Austria in January 2021.